Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050, United States.
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050, United States.
Curr Opin Struct Biol. 2020 Jun;62:183-188. doi: 10.1016/j.sbi.2020.02.004. Epub 2020 Apr 14.
Allosteric regulation of protein functions is ubiquitous in organismal biology, but the principles governing its evolution are not well understood. Here we discuss recent studies supporting the large-scale existence of latent allostery in ancestor proteins of superfamilies. As suggested, the evolution of allostery could be driven by the need for specificity in paralogs of slow evolving protein complexes with conserved active sites. The same slow evolution is displayed by purifying selection exhibited in allosteric proteins with somatic mutations involved in cancer, where disease-associated mutations are enriched in both orthosteric and allosteric sites. Consequently, disease-associated variants can be used to identify druggable allosteric sites that are specific for paralogs in protein superfamilies with otherwise similar functions.
蛋白质功能的变构调节在生物体内普遍存在,但控制其进化的原则还不是很清楚。在这里,我们讨论了最近的研究,这些研究支持超家族祖先蛋白中存在潜在变构的大规模存在。正如所建议的,变构的进化可能是由对具有保守活性位点的缓慢进化的蛋白质复合物的同源物的特异性的需求所驱动的。同样的缓慢进化也表现在涉及癌症的变构蛋白的纯化选择中,其中疾病相关的突变在正位和变构位点中都富集。因此,疾病相关的变体可以用于鉴定可成药的变构位点,这些位点是具有相似功能的蛋白质超家族中的同源物所特有的。